Cardiovascular disease and the UN Millennium Development Goals: a serious concern

Valentin Fuster

doi:10.1038/ncpcardio0630 | Full Text | PDF (74K)

Vascular access site complications after PCI: current status and future directions

Martial Hamon

doi:10.1038/ncpcardio0607 | Full Text | PDF (96K)

The metabolic syndrome predicts cardiovascular prognosis

doi:10.1038/ncpcardio0587 | Full Text | PDF (100K)

Candesartan is effective in treating prehypertension

doi:10.1038/ncpcardio0588 | Full Text | PDF (88K)

Imaging by 64-slice CT accurately diagnoses stenosis in CABG

doi:10.1038/ncpcardio0589 | Full Text | PDF (97K)

C-reactive protein levels are increased in active carotid artery plaques

doi:10.1038/ncpcardio0590 | Full Text | PDF (100K)

Atrioesophageal fistula: a potentially fatal complication of radiofrequency ablation

doi:10.1038/ncpcardio0591 | Full Text | PDF (96K)

Reduced neurohormone activation in patients with HF after aerobic physical training

doi:10.1038/ncpcardio0592 | Full Text | PDF (99K)

Treatment of aortic hypoplasia by stent expansion

doi:10.1038/ncpcardio0593 | Full Text | PDF (87K)

Microvolt T-wave alternans predicts mortality in patients with ischemic cardiomyopathy

doi:10.1038/ncpcardio0594 | Full Text | PDF (96K)

Sirolimus-eluting stents exhibit incomplete neointimal coverage

doi:10.1038/ncpcardio0595 | Full Text | PDF (99K)

Risk of cardiovascular disease very high in patients with type 1 diabetes

doi:10.1038/ncpcardio0596 | Full Text | PDF (97K)

Septal morphology is related to genotype in hypertrophic cardiomyopathy

doi:10.1038/ncpcardio0608 | Full Text | PDF (100K)

Ethnic differences in risk of MI among patients with ESRD

doi:10.1038/ncpneph0214 | Full Text | PDF (88K)

Growth hormone therapy has a positive effect on cardiovascular risk

doi:10.1038/ncpendmet0210 | Full Text | PDF (86K)

Combining prestroke treatments reduces stroke severity

doi:10.1038/ncpneuro0235 | Full Text | PDF (87K)

Can tailored ablation procedures successfully eliminate recurrent atrial fibrillation?

John M Miller and Girish V Nair

doi:10.1038/ncpcardio0627 | Full Text | PDF (97K)

Should patients with mitral stenosis and atrial fibrillation receive combined antithrombotic therapy?

Vittorio Pengo

doi:10.1038/ncpcardio0612 | Full Text | PDF (97K)

HOPE 2: can supplementation with folic acid and B vitamins reduce cardiovascular risk?

Iftikhar J Kullo

doi:10.1038/ncpcardio0611 | Full Text | PDF (101K)

Should all patients at high risk of atherothrombotic events receive dual antiplatelet therapy?

Karen E Thomas and Duane S Pinto

doi:10.1038/ncpcardio0628 | Full Text | PDF (98K)

Can brain natriuretic peptide be used to diagnose and manage patients with diastolic heart failure?

Burkert Pieske

doi:10.1038/ncpcardio0606 | Full Text | PDF (101K)

ASSENT-4 PCI: should facilitated percutaneous coronary intervention be used in clinical practice?

Kanwar P Singh and Matthew T Roe

doi:10.1038/ncpcardio0626 | Full Text | PDF (101K)

Should prophylactic amiodarone therapy be used to prevent atrial tachyarrhythmia after cardiac surgery?

Atul Verma, Subodh Verma, Lee Errett and Paul Dorian

doi:10.1038/ncpcardio0629 | Full Text | PDF (102K)

Update on lipid-lowering therapy and LDL-cholesterol targets

Stephen D Wiviott and Christopher P Cannon

doi:10.1038/ncpcardio0613 | Full Text | PDF (246K)

Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease

Mark E Anderson, Linda S Higgins and Howard Schulman

doi:10.1038/ncpcardio0585 | Full Text | PDF (260K)